Jan Hartmann, MD

Bringing Med to MedTech - Physician, Scientist, Photographer, Traveler, Berliner, Immigrant 🇩🇪🇺🇸 - Views=My own, Like/RT≠Endorsement; Haemonetics employee

[Jan Hartmann, MD @JanHartmannMD]

Like a Fine Wine—Aging the D-Dimer to Improve Value and Clinical Efficiency

Nice title for this editorial
https://t.co/M3iAPgJCgd

[Jan Hartmann, MD @JanHartmannMD]

Age-Adjusted D-Dimer Cutoff in Suspected Deep Vein Thrombosis https://t.co/uvdbVKtcnl

[Jan Hartmann, MD @JanHartmannMD]

Pre‐operative anaemia, red blood cell transfusion and mortality after cardiac surgery: a Netherlands Heart Registration mediation analysis - Groenewegen - Anaesthesia - Wiley Online Library https://t.co/Iomv0ehhJK

[Jan Hartmann, MD @JanHartmannMD]

Our article on the trial of the HN cartridge for the TEG® 6s system featured in current issue of ⁦⁦@_Anesthesiology.⁩
A big thank you to our team of co‑authors, local PIs and their teams, and all the participating patients who made this possible. https://t.co/UlavB8Y9nE

[Jan Hartmann, MD @JanHartmannMD]

TEG® 6s Heparin Neutralization Cartridge for Hemostatic... : Anesthesiology https://t.co/mJMX7ciM2o

[Jan Hartmann, MD @JanHartmannMD]

Rainbow over Sandy Bay – Rockport, MA 🌈 ⁦@RockportMA⁩ #rainbow

[Jan Hartmann, MD @JanHartmannMD]

Football & Freunde 🇩🇪🇺🇸 — Germany Day at ⁦@Patriots⁩ Training Camp 2025.
⁦@SebVollmer⁩ ⁦@themarkuskuhn⁩ ⁦@Fred_Kirsch⁩ ⁦@patsdeutsch⁩

[Jan Hartmann, MD @JanHartmannMD]

Fireworks over @RockportMA and the moon is watching…

[JACC Journals @JACCJournals]

Coagulation factor XI is a promising target for safer anticoagulants. In a series of preclinical studies, novel factor XI-targeting GalNAc-siRNA RBD4059 showed high potency & long-lasting antithrombotic effects w/out ⬆️ 🩸 risk. https://t.co/RG7cJJhyor

#JACCBTS #CardioX #cvCoag

[Jan Hartmann, MD @JanHartmannMD]

@MaryCushmanMD Budapest

[Jan Hartmann, MD @JanHartmannMD]

Last night at #ISTH2025, we honored a gentle giant—Dr. Hau Kwaan, Prof.em. at ⁦⁦@NorthwesternMed⁩. A true #Fibrinolysis pioneer with 400+ articles since the 1950s—still contributing posters in his 90s. Thanks, Mark Walsh, for a moving laudatio. https://t.co/noN0BkwD8p

[Jan Hartmann, MD @JanHartmannMD]

Public radio in Boston… 📻 ⁦@NPR⁩ ⁦@WBUR⁩ #BumpaSticka

[ASH @ASH_hematology]

Managing surgical bleeding is complex, but #viscoelastic testing is helping clinicians make more informed decisions. It can provide real-time insights and help guide targeted treatments to optimize perioperative and major bleeding management. https://t.co/drClsrxhk8

[Jan Hartmann, MD @JanHartmannMD]

https://t.co/KCvq9VNgq5

[Jan Hartmann, MD @JanHartmannMD]

This podcast episode with my favorite hematologist is a great resource for Sickle Cell Disease patients and their families and friends. #SCD https://t.co/QkXONtFUqt

[Jan Hartmann, MD @JanHartmannMD]

Emergent cardiac surgery, andexanet alfa–induced heparin resistance, a... https://t.co/6sdTsvcJLu

[Jan Hartmann, MD @JanHartmannMD]

Please discuss. I will observe… 🍿 🍿 🍿

“Overall, there was little to no evidence of a difference between blood transfusion strategies for mortality or thromboembolic events.”

https://t.co/k90Hv1eZkf

[Heart Rhythm Society @HRSonline]

Congratulations to Andrea Natale, MD, FHRS, winner of the 2025 Wilton Wells Webster Lectureship Award at #HRS2025. His lectureship was titled "Innovations in the Advancement of Care in Patients with AF in the Last 3 Decades: A Chronicle of My Journey." #EPeeps #LectureshipAward

[Jan Hartmann, MD @JanHartmannMD]

Looking forward to this event in June. Press release here: https://t.co/Ui8PMZQTG5

[NEJM @NEJM]

In the SINGLE SHOT CHAMPION trial, pulsed field ablation was noninferior to cryoballoon ablation with respect to the incidence of a first recurrence of atrial tachyarrhythmia, as assessed by continuous rhythm monitoring.

Full trial results and Research Summary: https://t.co/tQQasb3euV

#Afib